Published on in Vol 27 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/77720, first published .
Improving Recruitment Into Research Studies via Electronically Collected Patient-Entered Data: Mixed Methods Study

Improving Recruitment Into Research Studies via Electronically Collected Patient-Entered Data: Mixed Methods Study

Improving Recruitment Into Research Studies via Electronically Collected Patient-Entered Data: Mixed Methods Study

Original Paper

1Center for Outcomes Research & Evaluation, Neurological Institute, Cleveland Clinic, Cleveland, OH, United States

2Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, United States

3Market Research and Analytics, Cleveland Clinic, Cleveland, OH, United States

4Lieberman Research, Inc, Great Neck, NY, United States

5Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, United States

6Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States

Corresponding Author:

Irene Katzan, MD, MS

Center for Outcomes Research & Evaluation

Neurological Institute

Cleveland Clinic

9500 Euclid Avenue, S80

Cleveland, OH, 44195

United States

Phone: 1 2164452616

Email: katzani@ccf.org


Background: Patient recruitment remains a critical challenge in clinical research. Although the integration of electronically collected patient-entered data within clinical practices enables innovative recruitment approaches, existing methods present challenges such as increased patient burden and potential violation of autonomy. A more nuanced approach involves identifying patient attributes associated with higher propensity for research participation, enabling research teams to efficiently prioritize outreach efforts.

Objective: This study aims to (1) develop patient-reported questions reflecting perceptions about research participation and (2) determine whether patient responses are predictive of interest in joining a precision medicine registry.

Methods: This mixed methods study used an exploratory sequential design in 2 phases. Phase 1 involved cognitive interviews with 32 patients recruited through the Cleveland Clinic Healthcare Partners program to develop “research perception” questions. Participants evaluated 9 candidate questions that were based on a literature review of research participation factors. Three questions were selected for implementation. Phase 2 was a cross-sectional cohort study incorporating these 3 questions into routine electronic questionnaires completed by primary care patients through the patient portal. The study population included 1077 patients who completed both “research perception” and “research recruitment” questions between August 2018 and April 2019. Diagnostic accuracy was assessed using receiver operating characteristic curve analysis, and multivariable logistic regression models evaluated associations while adjusting for demographic and health factors.

Results: Phase 1 revealed strong research support among participants, with 97% (31/32) agreeing that research should be part of the institution’s mission and 100% (32/32) affirming that research enhances patient care. Phase 2 included 1077 patients (mean age 48.3, SD 16.3 years; 625/1065 female, 58.68%; 661/1005 White, 65.77%), of whom 278 (25.8%) expressed interest in being contacted about the precision medicine registry. Patients expressing interest were older and had worse self-reported health, more depressive symptoms, and greater social needs. “Strongly agree” and “very important” responses to any “research perception” question were significantly associated with study interest, with adjusted odds ratios ranging from 6.36 (95% CI 2.77-14.6) to 17.6 (95% CI 5.08-61.1; P<.001). The “research perception” questions demonstrated high sensitivity (>80%) but limited specificity (24%-31%).

Conclusions: Patient-reported questions assessing research participation likelihood can help identify patients more likely to enroll in clinical studies. This approach enables effective recruitment prioritization while preserving patient autonomy and reducing patient burden. High sensitivity makes these questions valuable as screening tools, although limited specificity suggests use for prioritizing rather than excluding participants. Further validation across different trial types and populations is warranted.

J Med Internet Res 2025;27:e77720

doi:10.2196/77720

Keywords



Background

Recruitment of patients into clinical research studies is a persistent and well-documented challenge [1]. The number of clinical trials open for patient enrollment has increased dramatically over time, growing from 4000 protocols in 2000 to more than 134,000 in 2023, which has intensified the challenge of patient recruitment [2]. Approximately 80% of clinical trials are delayed or terminated early because of recruitment problems [3]. Poor patient recruitment is the top cause of clinical trial delays [4]. Failure to meet recruitment goals delays treatment advances, threatens internal validity, and raises concerns about the generalizability of results [3]. There is a clear need to improve recruitment practices.

The integration of electronically collected patient-entered data within clinical practices offers innovative approaches to aid research recruitment [5,6]. While patient-entered data can help identify potential study participants through eligibility screening and interest assessment, these methods present distinct challenges. Using electronic patient questionnaires to screen for study eligibility, while seemingly straightforward, increases the burden of patient response and can create frustration among patients uninterested in research participation [7]. This approach also requires ongoing technical resources to maintain and update screening criteria as studies evolve. More problematically, additional recruitment outreach to patients who have declined participation via questionnaire violates patient autonomy—a cornerstone of ethical research [7]. This practice risks eroding trust in the health care system.

A more nuanced approach involves identifying a patient attribute associated with a higher propensity for research participation. This strategy enables research teams to prioritize outreach efforts efficiently to those with a higher likelihood of participating while avoiding prescribed eligibility criteria or direct elicitation of their interest in research. This method reduces the risk of alienating patients and reduces patient burden of questionnaire completion.

Objectives

The objectives of this study were to (1) identify patient-reported questions that reflect perceptions about participating in clinical research studies and (2) determine whether patient responses to these questions are predictive of interest in participating in a precision medicine research registry.


Overview

This was a mixed methods study that used an exploratory sequential design. It was conducted in 2 phases. Phase 1 was a qualitative analysis that informed the phase 2 quantitative study. In phase 1, cognitive interviews were conducted to identify attribute questions that would reflect the likelihood that patients would participate in a clinical research study. In phase 2, the relationship between patients’ responses to the questions, identified in phase 1, and their interest in learning more about an ongoing research study was assessed in patients seen in primary care clinics. The identified “research perception” questions were added to an electronic questionnaire set that patients routinely complete before primary care office visits. The set also included a question about interest in being contacted about an ongoing precision medicine registry (Figure 1).

Figure 1. Study workflow. *Cleveland Clinic health care partners are patients who volunteer to provide their perspective about the design and delivery of care.

Ethical Considerations

Phase 1 of this study was reviewed by the Cleveland Clinic Institutional Review Board and considered preparatory for research. Participants in phase 1 received an information sheet inviting them to participate in the cognitive interviews, which outlined the study’s purpose, participation requirements, and voluntary nature of their involvement. Each participant received a US $25 Amazon gift card as compensation. Phase 2 received exemption from the Cleveland Clinic Institutional Review Board (IRB 19-465), which determined that informed consent was not required for either phase of the study. Project data were securely stored and analyzed on Cleveland Clinic servers, with access restricted to authorized study personnel.

Phase 1: Qualitative Study to Identify Optimal Question on Perception of Research

Overview

Patients were recruited through the Cleveland Clinic Healthcare Partners program, which is comprised of patients who volunteer to provide their perspective about the design and delivery of care. Of the 4590 Healthcare Partners members, 1000 (21.79%) were randomly selected and sent an online invitation to participate in a cognitive interview. Of these 1000 patient panel members, 200 (20%) indicated interest in participating. Of these 200 potential participants, 32 (16%) were selected using purposive sampling to obtain a representation of patients across levels of patient-reported health status, sex, age, and race.

Cognitive Interviews

After informed consent, 30-minute patient interviews were conducted via videoconference calls between October 31, 2017, and November 14, 2017, to develop self-reported questions that would reflect patients’ likelihood of participating in a clinical research study. All sessions were conducted by an experienced qualitative researcher (RF) and audio recorded and transcribed.

The specific aims of the interviews were to (1) explore the factors that impact the decision to participate in clinical research; (2) evaluate the clarity of, and participant responses to, 9 potential questions; and (3) identify alternative questions that may reflect patients’ likelihood of participating in a research study that were not previously considered. The 9 potential questions were selected based on a literature review of factors considered important in patients’ decisions to participate in clinical research [8-20] as well as the feasibility of assessment through patient questionnaires. An interview guide was developed (Multimedia Appendix 1) that contained candidate “research perception” questions. Some of the candidate “research perception” questions focused on participants’ overall impression of research, while 2 questions asked about the relevance of potential benefit to the patient versus benefit to others. Several questions asked about different factors that may affect their decision to participate, such as risk, location, and time commitment. Finally, there was a question about the importance of being informed about ongoing research trials for which they would be eligible. Participants were asked to respond to each of the candidate “research perception” questions on a 4-point Likert scale. They were then asked to explain the reasons for their responses.

Qualitative Analysis

The study used a deductive and explanatory approach to qualitative analysis. This approach was chosen because it provided a more structured investigation, allowing for a comprehensive understanding of patients’ perspectives on the best question to assess their interest in participating in potential research projects [21]. Field notes were recorded for each interview and were supplemented by transcripts for verbatim quotes and details. Two qualitative analysts then coded the data for themes and subthemes under the supervision of the senior qualitative researcher (RF). The coding tree was organized into 4 overarching themes that were identified before the start of interviews as part of the research objectives: level of interest to participate and past participation in clinical research at Cleveland Clinic, general perceptions of the importance of clinical research, drivers to participate in clinical research, and areas for improvement to recruit appropriate patients into clinical research. These themes reflect attitudinal motivations that drive patients to participate in clinical research. Subthemes were developed to understand the more nuanced aspects of the data, including the varying drivers for participating in clinical research and recommendations to improve the patient recruitment process. The hierarchical structure of the content analysis was organized from general categories to specific topics. A summary report was developed that included findings with recommendations.

Phase 2: Cross-Sectional Cohort Study to Evaluate Questions From Phase 1

Overview

Phase 2 was a cross-sectional cohort study to evaluate whether the “research perception” questions identified in phase 1 could predict patient interest in an ongoing precision medicine research registry. From November 13, 2018, to April 19, 2019, the “research perception” questions from phase 1 were added to the standard patient questionnaires that patients routinely completed through the electronic health record (EHR) patient portal (MyChart [Epic Systems Corporation]) before their primary care visits. As part of the standard of care, patients complete these electronic questionnaires either through the patient portal before arrival or by using tablets and computer workstations after arrival. Patients may decline to complete questionnaires or skip individual questions, and responses are immediately available to health care providers within the EHR.

From May 9, 2017, to April 19, 2019, all patients at select primary care locations also answered a “research recruitment” question asking whether they were interested in being contacted to learn more about a precision medicine registry (Multimedia Appendix 2). They were asked this question only once. Those who expressed interest selected their preferred contact method (telephone or email) and were subsequently contacted by a research coordinator through a separate process unrelated to this study.

The phase 2 patient population included primary care patients who completed both the “research perception” and “research recruitment” questions during primary care visits between November 13, 2018, and April 19, 2019.

Study Variables

In addition to responding to the “research perception” and “research recruitment” questions, patients completed the Patient-Reported Outcomes Measurement Information System Global Health (PROMIS GH) scale, the Patient Health Questionnaire-2 (PHQ-2) depression screen, and internally developed social needs questions. The PROMIS GH is a widely used, generic health measure comprising 10 items that generate mental and physical health summary scores, with higher scores indicating better health status [22]. The PHQ-2 includes 2 items, with higher scores reflecting more severe depressive symptoms [23]. Scores above 3 are indicative of at least moderate depressive symptoms. The social needs questions had binary (yes or no) responses and asked the following: (1) “In the last 12 months, has it been hard for you to pay any of these bills?” (2) “In the last 12 months, have you had to forgo healthcare because you didn’t have a way to get there?” (3) “In the last 3 months, were you ever worried your food would run out before you could buy more?” (4) “In the last 12 months, did you ever sleep in a shelter or not have a steady place to live?”

Additional demographic variables extracted from the EHR included age, sex, race, marital status, and median household income estimated from the 2010 census using zip codes. The authors had full access to the data from the study population.

Analysis

Descriptive statistics were used to evaluate responses to the “research perception” questions and to compare the characteristics of patients according to their responses to the precision medicine “research recruitment” question. Characteristics were compared by response to the precision medicine “research recruitment” question using the 2-tailed t test for continuous variables and the chi-square test for categorical variables.

Multivariable logistic regression models were constructed to predict response to the “research recruitment” question. Each of the 3 “research perception” questions were included in separate models to evaluate the ability of these questions to independently predict patients’ interest in being contacted to learn more about the ongoing research study if combined with other clinical variables available in the EHR. The independent variable in these models was one of the “research perception” questions. The dependent variable was patient response to the “research recruitment” question. Covariates included age, sex, race, marital status, median household income, PROMIS GH physical and mental health summary scores, depressive symptoms based on the PHQ-2, and a positive response to any of the social needs questions. Interaction effects were also explored between the independent variables and age, sex, and race in separate models. Any significant interaction effects at P<.05 were included in the final models.

The diagnostic accuracy of the 3 “research perception” questions to predict positive response on the “research recruitment” question was assessed using receiver operating characteristic curve analysis. Area under the curve, the Youden index, sensitivity, specificity, negative predictive value, and positive predictive value were calculated for responses of “strongly agree” or “agree” as well as “very important” or “important” on the “research perception” questions. Statistical significance was established throughout at P<.05. All phase 2 analyses were conducted using SAS 9.4 (SAS Institute Inc).


Phase 1: Qualitative Data Collection

The 32 participants who completed the cognitive interviews had a range of self-reported health conditions. Of the 32 participants, 13 (41%) were female, 13 (41%) were aged 65 years or older, and 11 (34%) had previously participated in a clinical research study (Table 1).

Table 1. Characteristics of participants in cognitive interviews (phase 1; n=32)a.
CharacteristicsParticipants, n (%)
Age group (y)

21-547 (22)

55-6412 (37)

≥6513 (41)
Sex: female13 (41)
Participated in clinical research study at Cleveland Clinic11 (34)
Educational level

High school graduate3 (9)

Some college or graduated 2-year college9 (28)

Graduated 4-year college8 (25)

Postgraduate degree12 (37)
Race

Asian2 (6)

Black6 (19)

White22 (69)

Other2 (6)
Marital status

Married or partnered22 (69)

Single4 (12)

Divorced or widowed6 (19)
Self-reported health condition

Excellent8 (25)

Good8 (25)

Fair11 (34)

Poor5 (16)

aCognitive interviews were performed between October 31, 2017 and November 14, 2017 (for details, refer to the Cognitive Interviews subsection under Phase 1: Qualitative Study to Identify Optimal Question on Perception of Research) to identify a question that would best capture patients’ interest in participating in clinical research.

Data saturation was reached, with participants in the cognitive interviews voicing strong support for clinical research, recognizing its important role in advancing patient care advancement, and agreeing that it should be part of Cleveland Clinic’s mission (Table 2). Participants indicated that they preferred receiving information about research opportunities in person directly from their physicians, citing the trust-based relationship with their health care providers and their health care providers’ unique understanding of their medical needs. While participants also viewed emails, MyChart messages, and telephone calls as effective ways to learn about research eligibility, they wanted these to serve as secondary forms of communication after initial discussion with their physicians.

Participants held highly favorable views toward research, with 97% (31/32) agreeing or strongly agreeing that it should be part of the institution’s mission and 100% (32/32) affirming that research enhances patient care. Likewise, nearly all respondents indicated that they would consider participating in research if it benefited them (32/32, 100%) or others (31/32, 97%). Participants indicated that they feel it is important to help others, and many indicated feeling a sense of responsibility to give back; however, they would not participate in a clinical study to help others if they were physically or mentally harmed in the process. Of the 32 participants, 31 (97%) also expressed that it was important or very important to be informed about clinical research opportunities for which they were eligible. Furthermore, a few (2/32, 6%) said that they would be disappointed if their physician did not inform them about clinical studies for which they may be eligible candidates.

There was slightly less consensus on the significance of practical factors such as location, time commitment, and compensation (Table 3).

Participants found all questions to be clear and easy to understand, with no suggestions for additional questions. As the most effective question for gauging patients’ interest in research participation, they identified the following: “I would consider participating in a clinical research study if it could potentially help me.” This question, along with 2 other candidates, was chosen for piloting in clinical practice. The selection of these questions was based on participant feedback, the distribution of participant responses, and their perceived relevance. The additional 2 questions were the following: “I would consider participating in a clinical research study if it could potentially help others” and “How important do you feel it is for your healthcare provider to let you know of research trials for which you may be eligible?”

Table 2. Candidate “research perception” questions assessed in cognitive interviews and participant responses (phase 1; n=32)a. Participants responded to the following item: “Select the most appropriate response for each of the following questions.”
QuestionsStrongly agree, n (%)Agree, n (%)Disagree, n (%)Strongly disagree, n (%)
I feel that research should be part of Cleveland Clinic’s mission24 (75)7 (22)1 (3)0 (0)
I feel that research is important to be able to improve patient care28 (88)4 (12)0 (0)0 (0)
I would consider participating in a clinical research study if it could potentially help meb23 (72)9 (28)0 (0)0 (0)
I would consider participating in a clinical research study if it could potentially help othersb21 (66)10 (31)0 (0)1 (3)

aCognitive interviews were conducted between October 31, 2017 and November 14, 2017 (for details, refer to the Cognitive Interviews subsection under Phase 1: Qualitative Study to Identify Optimal Question on Perception of Research).

bThese questions were selected for pilot implementation in electronic questionnaires.

Table 3. Candidate “research perception” questions assessed in cognitive interviews and participant responses (phase 1; n=32)a. Participants responded to the following question: “How important would each of the following factors be in your decision to participate as a volunteer in a clinical research study?”
QuestionsVery important, n (%)Somewhat important, n (%)Not very important, n (%)Not at all important, n (%)
Level of personal risk for adverse health outcomes20 (63)9 (28)2 (6)1 (3)
The location of the clinical research study is easily accessible13 (50)7 (22)2 (6)7 (22)
Whether you would be paid to participate1 (3)10 (31)8 (25)13 (41)
The amount of time commitment to participate12 (41)8 (28)3 (10)6 (21)
How important do you feel it is for your healthcare provider to let you know of research trials for which you may be eligible?b22 (69)9 (28)0 (0)1 (3)

aCognitive interviews were performed between October 31, 2017 and November 14, 2017 (for details, refer to the Cognitive Interviews subsection under Phase 1: Qualitative Study to Identify Optimal Question on Perception of Research).

bThis question was selected for pilot implementation in electronic questionnaires.

Phase 2: Cross-Sectional Cohort Study

A total of 1077 patients completed the “research recruitment” question and at least 1 of the 3 “research perception” questions and were included in the study cohort (mean age 48.3, SD 16.3 years; 625/1065 female, 58.68%; 661/1005 White, 65.77%; Table 4). Mean PROMIS GH physical and mental health summary scores were 49.4, SD 8.8 and 49.6, SD 9.6, respectively, similar to the mean of the US general population. At least moderate depressive symptoms were indicated by 11% (106/936) of the patients. Moreover, 14.1% (148/1050) indicated that they had concerns about paying their bills, and 2.57% (27/1051) indicated that they had difficulty with transportation to their medical appointments.

Table 4. Characteristics of patients completing electronic questions stratified by interest in a precision medicine registry (phase 2)a.
CharacteristicsAll patients completing questionsPatients who did not wish to be contacted about the precision medicine registryPatients who wished to be contacted about the precision medicine registryP value
Age (y), mean (SD)48.3 (16.3)47.2 (16.4)51.4 (15.6)<.001
Female, n (%)625/1065 (58.7)457/789 (57.9)168/276 (60.9).35
Race, n (%).96

Black254/1005 (25.3)191/750 (25.5)63/255 (24.7)

White661/1005 (65.8)491/750 (65.5)170/255 (66.7)

Other90/1005 (9)67/750 (8.9)23/255 (9)
Married, n (%)530/1047 (50.6)394/780 (50.5)136/267 (50.9).90
Household income (in units of US $10,000), mean (SD)4.80 (2.04)4.81 (2.02)4.80 (21.1).94
Patient-reported outcomes, mean (SD)

PROMIS GHb


Physical health49.4 (8.8)50.4 (8.3)46.7 (9.4)<.001


Mental health49.6 (9.6)50.4 (9.4)47.3 (9.9)<.001

PHQ-2c depression screen0.78 (1.34)0.68 (1.27)1.05 (1.51)<.001


Depressed moodd, n (%)106/963 (11)68/711 (9.6)38/252 (15.1).02

Social needs questions, n (%)


Payment trouble148/1050 (14.1)84/777 (10.8)64/273 (23.4)<.001


Transportation trouble27/1051 (2.6)11/778 (1.4)16/273 (5.9)<.001


Food trouble431050 (4.1)19/777 (2.4)24/273 (8.8)<.001


Housing trouble28/1050 (2.7)14/777 (1.8)14/273 (5.1).003


Any social needs166/1050 (15.8)94/777 (12.1)72/273 (26.4)<.001

aPatients seen in primary care clinics completed these electronic patient-reported outcomes as part of the standard of care.

bPROMIS GH: Patient-Reported Outcomes Measurement Information System Global Health.

cPHQ-2: Patient Health Questionnaire-2.

dDepressed mood based on PHQ-2 score of ≥3.

Of the 1077 patients, 278 (25.8%) responded affirmatively to the “research recruitment” question, indicating that they were interested in being contacted about the precision medicine registry. Patients who responded affirmatively were older than those who responded no (mean 51.4, SD 15.6 years vs mean 47.2, SD 16.4 years), had worse self-reported physical and mental health conditions, were more likely to report depressive symptoms (38/252, 15.1% vs 68/708, 9.6%), and indicated more social needs (72/273, 26.4% vs 94/777, 12.1%).

The majority of the patients responded positively to the “research perception” questions: 75% (800/1067) agreed or strongly agreed that they would consider participating in a clinical research study if it could potentially help others, while 81.02% (858/1059) indicated that they would consider participating if it would help them (Figure 2). In addition, 72.96% (785/1076) of the respondents felt that it was important for their health care team to let them know of clinical research studies for which they may be eligible.

More positive responses to all 3 “research perception” questions were significantly associated with interest in the precision medicine registry. A dose-response relationship was demonstrated for the responses to each question (Table 5). For the question “I would consider participating in a clinical research study if it could potentially help others,” responses of “agree” and “strongly agree” were significantly associated with interest in the precision medicine registry (adjusted odds ratio 8.40, 95% CI 2.48-28.5 and adjusted odds ratio 17.6, 95% CI 5.08-61.1, respectively). The multivariable models incorporating demographic and health factors alongside “research perception” questions demonstrated superior discriminative ability compared to models using “research perception” questions alone, with C-statistic values ranging from 0.716 to 0.752 in adjusted models compared to values ranging from 0.628 to 0.650 in unadjusted models (Table 5). The highest discrimination was achieved by the model that included the “research perception” question “I would consider participating in a clinical research study if it could potentially help me” (C-statistic=0.752).

Figure 2. Responses to “research perception” questions (phase 2 cohort study).
Table 5. Multivariable logistic regression models predicting interest in a precision medicine registry based on “research perception” questions (phase 2)a.
Covariates and response optionsAdjusted odds ratio (95% CI)P valueC-statistic
I would consider participatingin a clinical research study if it could potentially help others”(reference: “strongly disagree”)0.746

Disagree2.39 (0.66-8.71).19

Agree8.40 (2.48-28.5)<.001

Strongly agree17.6 (5.08-61.1)<.001
I would consider participating in a clinical research study if it could potentially help me”b(reference: “strongly disagree”)0.752

Disagree1.14 (0.29-4.55).85

Agree5.50 (1.63-18.5).006

Strongly agree11.1 (3.28-37.8)<.001
How important do you feel it is for your healthcare provider to let you know of research trials for which you may be eligible?” (reference: “not at all important”)0.716

Not very important2.23 (0.91-5.48).28

Somewhat important2.91 (1.26-6.72).01

Very important6.36 (2.77-14.6)<.001

aThe independent variables in these models were the “reception perception” questions, and the dependent variable was interest in the precision medicine research registry. The models adjusted for age, sex, race, marital status, median household income, depressive symptoms, Patient-Reported Outcomes Measurement Information System Global Health, any social needs, and significant interactions.

bSignificant interaction with current age; estimates presented for the model without the interaction effect.

The “research perception” questions demonstrated high sensitivity but limited specificity (Table 6). For responses of “agree” or “strongly agree” or “important” or “very important,” sensitivity exceeded 85% across all questions. Similarly high negative predictive values (>85%) indicated that patients who responded negatively to these questions were unlikely to express interest in the precision medicine registry. However, the questions demonstrated low specificity (24%-31%) and positive predictive values (30%), indicating that positive responses were not strong predictors of actual interest in the precision study.

Table 6. Unadjusted diagnostic accuracy of primary care patients’ responses to the 3 “research perception” questions in predicting patients’ interest in learning more about the precision medicine registry (phase 2).
Variables“Research perception” questions

“I would consider participating in a clinical research study if it could potentially help others”: “strongly agree” or “agree”“I would consider participating in a clinical research study if it could potentially help me”: “strongly agree” or “agree”“How important do you feel it is for your healthcare provider to let you know of research trials for which you may be eligible?”: “very important” or “important”
AUCa0.6280.6500.636
Youden index0.1830.1860.158
Sensitivity (%)88.494.684.9
Specificity (%)302431
PPVb (%)30.730.330
NPVc (%)8892.785.5

aAUC: area under the curve.

bPPV: positive predictive value.

cNPV: negative predictive value.


Principal Findings

This study demonstrated that the response to 1 question added to electronic patient questionnaire sets about patient perceptions regarding research may help prioritize recruitment efforts to patients who are more likely to participate in clinical research studies.

There are several potential approaches to using patient-entered data to aid in research recruitment (Table 7), with each having distinct advantages and limitations. While methods that directly assess patient eligibility and interest by using screening questions can reduce the research team’s workload, practical constraints within clinical care settings often limit their feasibility and may compromise respect for patient preferences.

Table 7. Options for using patient-entered data to aid patient recruitment into clinical trials.
OptionsStrengthsLimitations
1. Ask specific eligibility questions for each clinical trial
  • Most directly useful
  • Does not require patient to indicate interest in research
  • Adds to patient burden from question completion
  • Most resource-intensive option to build and maintain
  • May require preceding patient consent to ask research eligibility questions or have the ability for patients to opt out
2. Ask common eligibility questions that can be used across the clinical trials for each area
  • Requires fewer resources to update than option 1
  • Does not require patients to indicate interest in research
  • Adds to patient burden from question completion
  • Requires build of custom questions for each research area
  • May require preceding patient consent to ask research eligibility questions or have the ability for patients to opt out
3. Ask about general interest in participating in, or being contacted about, research
  • Simpler to implement
  • Can be used to prioritize patients to approach about specific trials
  • Soliciting research participation from patients who have explicitly declined interest represents a violation of their autonomy
  • Patients who respond “not interested” to the patient-entered data question may still be interested upon discussion with their care providers
  • Must assess preliminary study eligibility through another route
4. Ask general question about perception of research (treat as “patient attribute”)
  • Simpler to implement
  • Can be used to prioritize patients to approach about specific trials
  • Efficacy of this approach requires empirical testing
  • Must assess preliminary study eligibility through another route

Capturing patients’ attitudes toward research offers a balanced solution that preserves autonomy and prevents the frustration that may occur when those who have explicitly declined contact about research are nonetheless approached. In addition, this approach is concise, straightforward to implement, and requires minimal ongoing maintenance.

The question “I would consider participating in a clinical research study if it could potentially help me” demonstrated superior performance metrics, with both a higher area under the curve and greater sensitivity compared to the alternative questions. However, its direct personal nature may make it less suitable for integration into general clinical questionnaires. Conversely, the question “How important do you feel it is for your healthcare provider to let you know of research trials for which you may be eligible” had the lowest C-statistic value and sensitivity but may have a better contextual fit within standard previsit questionnaires, potentially making it more practical for routine clinical implementation. Specificity was relatively low for all questions; in this context, optimizing sensitivity over specificity can be considered advantageous, as it minimizes the risk of missing potentially interested participants while accepting a higher rate of false positives.

The cognitive interviews revealed that patients prefer to hear about research opportunities directly from their physician. A preference for health care provider to patient discussion about research has been noted by others [24-26]. Incorporating “research perception” questions within the clinical workflow supports this preference by enabling physicians to prioritize recruitment efforts during their office visit based on patient responses indicating an interest in research. This approach is used by the Movement Disorder Section of the Neurological Institute at our health system, where patients answer the “research perception” question “I think it’s important to be told of research trials for which I may be eligible” alongside other clinical questions before their visit. In the experience of the authors, this screening method has proven effective in prompting clinicians to spend additional time discussing relevant studies with patients who express interest.

Our adjusted models, which contained a “research perception” question and additional variables, had improved discriminative capacity. If electronically implemented, they could allow a more precise estimation of patients’ interest in research. However, targeting participants based on demographic and health status characteristics could introduce greater patient selection bias, reducing a study’s generalizability. Adjusted models would also be more resource intensive to implement.

Recent advances in EHR systems, apart from patient-entered data functionality, have also streamlined the patient recruitment process for clinical research. Many now have query capabilities that enable research teams to efficiently identify potentially eligible patients by searching structured data fields for specific eligibility criteria [27]. This automation has reduced the need for developing custom patient questionnaires to screen patients for eligibility. Artificial intelligence applied to EHR records can also now screen patients for eligibility criteria [28,29]. In addition, EHR systems can now directly engage potential participants through patient portals, automatically notifying them of trials that match their clinical profile. Although only a small percentage of patients contacted this way enroll as participants, this approach is effective at increasing recruitment because of the large volume of patients contacted through patient portal messages [30-32]. Integrating this EHR-based recruitment method with the patient attribute question can create a synergistic approach to optimize patient enrollment. Using multiple recruitment methods can increase enrollment yield [33,34].

Although this study was conducted at a single institution, the proposed approach is readily adaptable to other health systems that routinely collect patient-reported data during clinical visits. As technology advances, patient-reported data collection is becoming increasingly commonplace [35]. Adding a single question that requires no score calculations to existing questionnaire sets is straightforward and minimally increases the burden of patient response.

Limitations

Several important limitations should be noted. First, although participants in the cognitive interviews reported a wide range of health conditions, they had more education than the general population, and approximately one-third of the interviewees (11/32, 34%) had previously participated in a clinical research study. Their opinions may differ from those with different educational backgrounds and experience with clinical research. Second, our assessment focused solely on the relationship between “research perception” questions and interest in a precision medicine registry. Patient attitudes may vary substantially across different types of clinical research. Third, responses to research participation questions might differ significantly if patients were facing an actual serious medical diagnosis rather than a hypothetical scenario. Fourth, our methodology for maintaining screening logs limited our ability to track actual study participation in the precision medicine registry. Instead, we could only measure the relationship between “research perception” questions and patients’ initial interest in learning more about the study. Finally, relying on patient-entered questionnaires as a screening tool has inherent limitations. This approach would only capture data from patients who complete electronic questionnaires, potentially underrepresenting racial and ethnic minority groups or populations considered vulnerable who may have limited access to patient portals [36].

Conclusions

The ability to identify patients who have a greater likelihood of participating in research studies by assessing patients’ attitudes toward research is a helpful tool to aid patient recruitment into clinical research. This approach allows research teams to prioritize their recruitment efforts more effectively without relying on strict eligibility criteria. It provides a framework for more nuanced and respectful engagement in the recruitment process, ultimately serving both research efficiency and patient experience. The use of broad indicators rather than specific eligibility questions creates a more flexible and sustainable recruitment strategy that respects patient preferences while maximizing research participation opportunities. Further evaluation of this approach is warranted to assess the ability to use patient-reported questions on attitudes toward research for other types of clinical trials that vary by risk of adverse outcomes, level of patient burden, and health condition.

Acknowledgments

This work was supported by the Cleveland Clinic Center for Clinical Genomics.

Data Availability

The datasets generated and analyzed during this study are available from the corresponding author on reasonable request.

Authors' Contributions

Conceptualization: IK, WHWT, BL

Funding acquisition and resources: WHWT

Methodology: IK, RF, BL, AS, MA, MG

Analysis: RF, BL, RH

Writing – original draft: IK

Writing – review and editing: IK, WHWT, AS, RH, RF, MA, MG, BW, BL

Project administration and supervision: AS, MA, MG

Conflicts of Interest

None declared.

Multimedia Appendix 1

Interview guide.

DOC File , 75 KB

Multimedia Appendix 2

Precision medicine registry recruitment questionnaire.

DOCX File , 41 KB

  1. Wandile PM. Patient recruitment in clinical trials: areas of challenges and success, a practical aspect at the private research site. J Biosci Med. Oct 2023;11(10):103-113. [CrossRef]
  2. Foster R. Five challenges to clinical trials access and recruitment. Cure. Mar 8, 2024. URL: https:/​/wewillcure.​com/​insights/​entrepreneurship/​regulatory-and-clinical-strategy/​five-challenges-to-clinical-trials-access-and-recruitment [accessed 2025-09-20]
  3. Yardi S. Clinical trials statistics 2025 by phases, definition and interventions. Market.us Media. Jan 13, 2025. URL: https://media.market.us/clinical-trials-statistics/ [accessed 2025-09-20]
  4. Brøgger-Mikkelsen M, Ali Z, Zibert JR, Andersen AD, Thomsen SF. Online patient recruitment in clinical trials: systematic review and meta-analysis. J Med Internet Res. Nov 04, 2020;22(11):e22179. [FREE Full text] [CrossRef] [Medline]
  5. Verdini NP, Bryl KL, Baser RE, Lapen K, Mao JJ, Gillespie EF. Patient-reported outcomes as a recruitment strategy for clinical trial enrollment. JAMA Oncol. Jun 01, 2024;10(6):784-788. [CrossRef] [Medline]
  6. Zihang C, Liang L, Qianmin S, Gaoyi C, Jihan H, Ying L. Enhanced pre-recruitment framework for clinical trial questionnaires through the integration of large language models and knowledge graphs. Sci Rep. Jul 28, 2025;15(1):27398. [FREE Full text] [CrossRef] [Medline]
  7. Cruz Rivera S, Aiyegbusi OL, Ives J, Draper H, Mercieca-Bebber R, Ells C, et al. Ethical considerations for the inclusion of patient-reported outcomes in clinical research: the PRO ethics guidelines. JAMA. May 17, 2022;327(19):1910-1919. [CrossRef] [Medline]
  8. Avis NE, Smith KW, Link CL, Hortobagyi GN, Rivera E. Factors associated with participation in breast cancer treatment clinical trials. J Clin Oncol. Apr 20, 2006;24(12):1860-1867. [CrossRef]
  9. Liu HE, Li MC. Factors influencing the willingness to participate in medical research: a nationwide survey in Taiwan. PeerJ. 2018;6:e4874. [FREE Full text] [CrossRef] [Medline]
  10. Bernstein SL, Feldman J. Incentives to participate in clinical trials: practical and ethical considerations. Am J Emerg Med. Sep 2015;33(9):1197-1200. [FREE Full text] [CrossRef] [Medline]
  11. Al-Shami KM, Ahmed WS, Alzoubi KH. Motivators and barriers towards clinical research participation: a population-based survey from an Arab MENA country. PLoS One. 2022;17(6):e0270300. [FREE Full text] [CrossRef] [Medline]
  12. Kurt A, Kincaid HM, Curtis C, Semler L, Meyers M, Johnson M, et al. Factors influencing participation in clinical trials: emergency medicine vs. other specialties. West J Emerg Med. Aug 2017;18(5):846-855. [FREE Full text] [CrossRef] [Medline]
  13. Gayet-Ageron A, Rudaz S, Perneger T. Study design factors influencing patients' willingness to participate in clinical research: a randomised vignette-based study. BMC Med Res Methodol. Apr 26, 2020;20(1):93. [FREE Full text] [CrossRef] [Medline]
  14. George S, Duran N, Norris K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health. Feb 2014;104(2):e16-e31. [CrossRef] [Medline]
  15. Limkakeng AT, de Oliveira LL, Moreira T, Phadtare A, Garcia Rodrigues C, Hocker MB, et al. Systematic review and metasummary of attitudes toward research in emergency medical conditions. J Med Ethics. Jun 2014;40(6):401-408. [CrossRef] [Medline]
  16. Kurt A, Semler L, Jacoby JL, Johnson MB, Careyva BA, Stello B, et al. Racial differences among factors associated with participation in clinical research trials. J Racial Ethn Health Disparities. Sep 08, 2016. [CrossRef] [Medline]
  17. Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. Jan 15, 2008;112(2):228-242. [FREE Full text] [CrossRef] [Medline]
  18. Schmotzer GL. Barriers and facilitators to participation of minorities in clinical trials. Ethn Dis. 2012;22(2):226-230. [Medline]
  19. Agoritsas T, Deom M, Perneger TV. Study design attributes influenced patients' willingness to participate in clinical research: a randomized vignette-based study. J Clin Epidemiol. Jan 2011;64(1):107-115. [CrossRef] [Medline]
  20. Lanfear DE, Jones PG, Cresci S, Tang F, Rathore SS, Spertus JA. Factors influencing patient willingness to participate in genetic research after a myocardial infarction. Genome Med. Jun 15, 2011;3(6):39. [FREE Full text] [CrossRef] [Medline]
  21. Fife ST, Gossner JD. Deductive qualitative analysis: evaluating, expanding, and refining theory. Int J Qual Methods. Mar 28, 2024;23. [FREE Full text] [CrossRef]
  22. Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. Sep 2009;18(7):873-880. [FREE Full text] [CrossRef] [Medline]
  23. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. Nov 2003;41(11):1284-1292. [CrossRef] [Medline]
  24. Van Hoye G, Weijters B, Lievens F, Stockman S. Social influences in recruitment: when is word‐of‐mouth most effective? Int J Sel Assess. Feb 18, 2016;24(1):42-53. [CrossRef]
  25. Baquet CR, Commiskey P, Daniel Mullins C, Mishra SI. Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev. Jan 2006;30(1):24-33. [FREE Full text] [CrossRef] [Medline]
  26. Albrecht TL, Eggly SS, Gleason ME, Harper FW, Foster TS, Peterson AM, et al. Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol. Jun 01, 2008;26(16):2666-2673. [FREE Full text] [CrossRef] [Medline]
  27. Lai YS, Afseth JD. A review of the impact of utilising electronic medical records for clinical research recruitment. Clin Trials. Apr 2019;16(2):194-203. [CrossRef] [Medline]
  28. Chow R, Midroni J, Kaur J, Boldt G, Liu G, Eng L, et al. Use of artificial intelligence for cancer clinical trial enrollment: a systematic review and meta-analysis. J Natl Cancer Inst. Apr 11, 2023;115(4):365-374. [FREE Full text] [CrossRef] [Medline]
  29. Unlu O, Varugheese M, Shin J, Subramaniam SM, Stein DW, St Laurent JJ, et al. Manual vs AI-assisted prescreening for trial eligibility using large language models-a randomized clinical trial. JAMA. Mar 25, 2025;333(12):1084-1087. [CrossRef] [Medline]
  30. Beaton M, Jiang X, Minto E, Lau CY, Turner L, Hripcsak G, et al. Using patient portals for large-scale recruitment of individuals underrepresented in biomedical research: an evaluation of engagement patterns throughout the patient portal recruitment process at a single site within the All of Us Research Program. J Am Med Inform Assoc. Oct 01, 2024;31(10):2328-2336. [CrossRef] [Medline]
  31. Miller HN, Gleason KT, Juraschek SP, Plante TB, Lewis-Land C, Woods B, et al. Electronic medical record-based cohort selection and direct-to-patient, targeted recruitment: early efficacy and lessons learned. J Am Med Inform Assoc. Nov 01, 2019;26(11):1209-1217. [FREE Full text] [CrossRef] [Medline]
  32. Miller HN, Lindo S, Fish LJ, Roberts J, Stover J, Schwark EH, et al. Describing current use, barriers, and facilitators of patient portal messaging for research recruitment: perspectives from study teams and patients at one institution. J Clin Transl Sci. 2023;7(1):e96. [FREE Full text] [CrossRef] [Medline]
  33. Pfaff E, Lee A, Bradford R, Pae J, Potter C, Blue P, et al. Recruiting for a pragmatic trial using the electronic health record and patient portal: successes and lessons learned. J Am Med Inform Assoc. Jan 01, 2019;26(1):44-49. [FREE Full text] [CrossRef] [Medline]
  34. Beskow LM, Brelsford KM, Hammack CM. Patient perspectives on use of electronic health records for research recruitment. BMC Med Res Methodol. Feb 26, 2019;19(1):42. [FREE Full text] [CrossRef] [Medline]
  35. Terwee CB, Cella D. Embracing the future of patient-centered care with advances in patient-reported outcomes. Adv Patient Reprod Outcomes. Mar 2025;1(1):100001. [CrossRef]
  36. Tuan WJ, Mellott M, Arndt BG, Jones J, Simpson AN. Disparities in use of patient portals among adults in family medicine. J Am Board Fam Med. 2022;35(3):559-569. [FREE Full text] [CrossRef] [Medline]


EHR: electronic health record
PHQ-2: Patient Health Questionnaire-2
PROMIS GH: Patient-Reported Outcomes Measurement Information System Global Health


Edited by A Stone, A Mavragani; submitted 19.May.2025; peer-reviewed by A Debbarma, R Omachonu; comments to author 07.Aug.2025; revised version received 28.Aug.2025; accepted 23.Sep.2025; published 29.Oct.2025.

Copyright

©Irene Katzan, WH Wilson Tang, Andrew Schuster, Ryan Honomichl, Misti Allison, Renee Feldman, Michelle Gandolf, Benjamin Walter, Brittany Lapin. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 29.Oct.2025.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.